Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 3 hours 14 min ago

Chiesi’s $1.25B Amryt Buy Pays Off with FDA Approval of Filsuvez

Wed, 12/20/2023 - 02:00
Chiesi’s $1.25B Amryt Buy Pays Off with FDA Approval of Filsuvez 12/20/2023

Every move you make: biopharma industry under heavy scrutiny

Wed, 12/20/2023 - 02:00
Every move you make: biopharma industry under heavy scrutiny 12/20/2023

Biogen Secures Tecfidera Exclusivity in EU Until Early 2025

Wed, 12/20/2023 - 02:00
Biogen Secures Tecfidera Exclusivity in EU Until Early 2025 12/20/2023

Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown

Wed, 12/20/2023 - 02:00
Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown 12/20/2023

Merck Secures FDA Decision Date for Pneumococcal Vaccine, Race Heats Up with Pfizer

Wed, 12/20/2023 - 02:00
Merck Secures FDA Decision Date for Pneumococcal Vaccine, Race Heats Up with Pfizer 12/20/2023

German Court Nullifies CureVac’s Patent Case Against BioNTech

Wed, 12/20/2023 - 02:00
German Court Nullifies CureVac’s Patent Case Against BioNTech 12/20/2023

UniQure Touts Phase I/II Results for Huntington’s Disease Candidate, Wall Street Balks

Wed, 12/20/2023 - 02:00
UniQure Touts Phase I/II Results for Huntington’s Disease Candidate, Wall Street Balks 12/20/2023

Compass Pathways’ Psilocybin Treatment ‘Well-Tolerated’ in Phase II PTSD Trial

Wed, 12/20/2023 - 02:00
Compass Pathways’ Psilocybin Treatment ‘Well-Tolerated’ in Phase II PTSD Trial 12/20/2023

Q&A: JLL Analyst Mark Bruso on Biopharma Venture Capital Activity

Wed, 12/20/2023 - 02:00
Q&A: JLL Analyst Mark Bruso on Biopharma Venture Capital Activity 12/20/2023

Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review

Wed, 12/20/2023 - 02:00
Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review 12/20/2023

Gilead, Compugen Ink Potential $848M Deal for Preclinical Immunotherapy

Tue, 12/19/2023 - 02:00
Gilead, Compugen Ink Potential $848M Deal for Preclinical Immunotherapy 12/19/2023

Activist Investor Icahn Targets Illumina Board Amid GRAIL Divestiture

Tue, 12/19/2023 - 02:00
Activist Investor Icahn Targets Illumina Board Amid GRAIL Divestiture 12/19/2023

Bluebird Looks to Raise $250M After Lukewarm Reception of SCD Gene Therapy

Tue, 12/19/2023 - 02:00
Bluebird Looks to Raise $250M After Lukewarm Reception of SCD Gene Therapy 12/19/2023

Novo Nordisk Foundation Pumps $260M into Vaccines for Respiratory Diseases

Tue, 12/19/2023 - 02:00
Novo Nordisk Foundation Pumps $260M into Vaccines for Respiratory Diseases 12/19/2023

GSK’s Jemperli-Zejula Combo Aces Phase III Trial in Endometrial Cancer

Tue, 12/19/2023 - 02:00
GSK’s Jemperli-Zejula Combo Aces Phase III Trial in Endometrial Cancer 12/19/2023

EMA Committee Votes Against Renewing Marketing Authorization for GSK’s Blenrep

Fri, 12/15/2023 - 02:00
EMA Committee Votes Against Renewing Marketing Authorization for GSK’s Blenrep 12/15/2023

MindMed Posts Positive Phase II Results for LSD-Based Treatment for Anxiety

Fri, 12/15/2023 - 02:00
MindMed Posts Positive Phase II Results for LSD-Based Treatment for Anxiety 12/15/2023

Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election

Fri, 12/15/2023 - 02:00
Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election 12/15/2023

Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024

Fri, 12/15/2023 - 02:00
Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024 12/15/2023

Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition

Fri, 12/15/2023 - 02:00
Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition 12/15/2023